Hamilton Square Partners Management

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
	Crossbow Therapeutics	$77.0M Crossbow Therapeutics Series B	Taiho Ventures, Arkin Bio Ventures, Sakae Asanuma, Pini Orbach, Pini Orbach, Sakae Asanuma	BVF Partners, Eli Lilly and Company, Libbs Ventures, LifeLink, Mirae Asset Venture Investment, MPM Capital, Polaris Partners, Sixty Degree Capital, The Leukemia & Lymphoma Society

Total Raised

N/A

Valuation

N/A